Drug Topics
NOVEMBER 30, 2023
Federal guidance from the United States Pharmacopeia characterizes the practice as drug compounding, which pharmacists fear may drive up prices.
PharmaVoice
NOVEMBER 30, 2023
John Mulligan, founder of biotechs like Good Therapeutics and Bonum Therapeutics, discusses how biotechs can thrive when the market is against them.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
NOVEMBER 30, 2023
Prior research has shown the association between various socioeconomic variables and lower adherence to diabetic retinopathy screening, but few have elaborated on the patient perspective to understand the reason behind this association.
Pharmacy Times
NOVEMBER 30, 2023
Patients hospitalized for traumatic brain injury have different brain injury biomarkers and rates of glucose variation.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
NOVEMBER 30, 2023
ASHEVILLE, N.C. — There was the beeping of monitors, the stiff sheets, the sterile smell of the hospital room. Mostly, there was pain. Sharp, relentless pain. Mike Messino was recovering from a successful surgery, but the nerve blocks had worn off. He spent two full hours waiting for a nurse to inject pain medication. When he’d worked in this hospital, he’d made sure patients didn’t wait longer than 15 minutes for that kind of care.
Fierce Pharma
NOVEMBER 30, 2023
With layoffs hitting employees on both sides of the Atlantic, Pfizer’s $3.5 billion cost-cutting spree has kicked it into high gear this month. | The company's Groton, Connecticut, research site is the latest to fall victim to job cuts as part of Pfizer's massive $3.5 billion cost-cutting mission, following layoffs across the U.S. and the U.K.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Healthcare
NOVEMBER 30, 2023
Hospitals across multiple states have reopened their emergency rooms but continue to face disruptions after parent company Ardent Health Services was hit by a ransomware attack a week ago. | Hospitals across multiple states have reopened their emergency rooms but continue to face disruptions after parent company Ardent Health Services was hit by a ransomware attack a week ago.
STAT
NOVEMBER 30, 2023
AbbVie will pay $10 billion for the biotech firm Immunogen, the company said Thursday, acquiring an approved treatment for ovarian cancer and buying into a burgeoning area of oncology. Under the agreement, AbbVie will pay $31.26 per share in cash for Immunogen, a nearly 100% premium to the company’s recent trading price. Central to the deal, expected to close in the middle of next year, is Elahere, an Immunogen product that won Food and Drug Administration approval for advanced ovarian ca
Fierce Healthcare
NOVEMBER 30, 2023
Walgreens launched a new digital marketplace designed to help customers save money on prescription medications. | Walgreens launched a new digital marketplace designed to help customers save money on prescription medications. The move from Walgreens comes as brick-and-mortar retail pharmacies are feeling the heat from new online pharmacies that focus on lowering drug costs.
STAT
NOVEMBER 30, 2023
The Texas attorney general has filed a lawsuit accusing Pfizer of “unlawfully” and “intentionally” misrepresenting the effectiveness of its Covid-19 vaccine and attempting to censor its critics. The pharmaceutical company violated a state law — the Texas Deceptive Trade Practices Act — by making unsupported claims that its shot was durable and capable of protecting against transmission, according to the 54-page lawsuit filed in a state court by Texas Att
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
NOVEMBER 30, 2023
Patients with uncontrolled chronic obstructive pulmonary disease and type 2 inflammation had significantly better lung function at least a year into dupilumab regimen.
STAT
NOVEMBER 30, 2023
In June 2023, the Pregnant Workers Fairness Act (PWFA) went into effect. The federal law requires employers to give pregnant employees reasonable accommodations, such as getting appropriately sized uniforms or having closer parking. Another federal law, included in the December 2022 consolidated appropriations bill, now requires employers to provide break times for parents who need to pump breast milk during work hours.
Pharmacy Times
NOVEMBER 30, 2023
With wider testing available, diagnosing COVID-19 has become easier and many patients now have access to important treatment options.
Fierce Healthcare
NOVEMBER 30, 2023
Healthcare giant UnitedHealth Group hosted its annual investor conference this week, where it detailed key strategic initiatives ranging from value-based care to consumerism. | Healthcare giant UnitedHealth Group hosted its annual investor conference this week, where it detailed major strategic initiatives ranging from value-based care to consumerism.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
NOVEMBER 30, 2023
Melatonin is not fully regulated by the FDA, and there are concerns about children taking the supplement due to associated risks, such as dependency and overdose.
Fierce Healthcare
NOVEMBER 30, 2023
Virtual care giant Teladoc recently expanded its telehealth services to include prescribing obesity drugs as it eyes opportunities in the booming weight management market. | The employer market continues to be in a state of flux over coverage of pricey GLP-1 drugs, according to Teladoc CEO Jason Gorevic. Many are turning to virtual weight management solutions, like the one offered by his company, to help manage costs.
Pharmacy Times
NOVEMBER 30, 2023
An animal study shows that early-life stress may increase risk-taking behaviors in adulthood; in humans, this could translate to risk of substance use disorder.
STAT
NOVEMBER 30, 2023
Worried about your health? You can now avail yourself of noninvasive diagnostics that claim to screen for rare birth defects, cancer-associated mutations, and even Alzheimer’s. Even before the Covid pandemic, a 2018 paper reported that new genetic tests, many of them for increasingly rare conditions, were being released at the rate of 10 a day.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
NOVEMBER 30, 2023
These findings could make a significant difference in treating patients with Barth syndrome, which is an incurable genetic disease.
STAT
NOVEMBER 30, 2023
Many commonly suggested ways to addressing climate change present few ethical challenges: Cut fossil fuels. Eat less meat. Don’t buy fast fashion. But what happens when products that contribute to climate change also save lives — millions of them? A new report , published on Nov. 28 by the global health initiative Unitaid, looks into this issue, quantifying the environmental impact of 10 essential public health items.
Pharmacy Times
NOVEMBER 30, 2023
By strengthening the continent's health care infrastructure, promoting local vaccine production, and facilitating global collaborations, the grant represents an important milestone toward better health care for all Africans.
Fierce Pharma
NOVEMBER 30, 2023
The sizzling antibody-drug conjugate (ADC) field is at the center of another major life sciences deal. | The sizzling antibody-drug conjugate field is at the center of another major life sciences deal. Hoping to redeem itself following the epic Rova-T failure, AbbVie is shelling out $10.1 billion in cash to acquire ImmunoGen, maker of the ovarian cancer treatment Elahere.
Pharmacy Times
NOVEMBER 30, 2023
Nacre may combat cortical bone loss and improve bone strength to reduce risk of fragility fractures.
pharmaphorum
NOVEMBER 30, 2023
AbbVie has moved to shore up its pipeline following the loss of patent protection for its top-selling drug with a $10.1 billion deal to buy ImmunoGen and its marketed ovarian cancer drug.
Fierce Healthcare
NOVEMBER 30, 2023
By Marcus Perez, President, Altera Digital Health | Elevating healthcare for all starts with your EHR. With better usability, interoperability and infrastructure, next-level healthcare is within reach.
pharmaphorum
NOVEMBER 30, 2023
FDA chief scientist Namandjé Bumpus has been named as principal deputy commissioner, replacing long-serving Janet Woodcock when she steps down early next year. Bumpus is heading for the number two position at the FDA – second only to Commissioner Robert Califf who announced the appointment on X (formerly Twitter) – just over a year after she joined the agency.
The Checkup by Singlecare
NOVEMBER 30, 2023
Zyrtec (cetirizine) is a popular over-the-counter antihistamine used to treat allergy symptoms like sneezing, stuffy or runny nose, and itching. Being pregnant doesn’t make you immune from allergies—and, in some cases, many find that their allergy symptoms actually get worse during pregnancy. So it’s understandable to wonder if you can take Zyrtec while expecting.
Fierce Healthcare
NOVEMBER 30, 2023
Wellvolution, a digital health platform by Blue Shield of California, will now be more inclusive and accessible for Spanish speakers. | Blue Shield of California is aiming to make its Wellvolution offerings available to more members by including Spanish language capabilities and access to Dario.
European Pharmaceutical Review
NOVEMBER 30, 2023
Biocon Biologics Ltd has successfully completed integration of Viatris’ biosimilar business in 31 European countries. Following the acquisition of substantially all global biosimilar business of Viatris in November 2022, and the related integration of over 70 emerging market countries in July 2023 and North America in September 2023, now that Viatris’ biosimilars operations have fully transitioned to Biocon Biologics Ltd in Europe, the company declared that this “represents another significant m
pharmaphorum
NOVEMBER 30, 2023
UK Biobank releases largest-ever genome sequencing dataset Phil.
Drug Store News
NOVEMBER 30, 2023
The report summarizes the proceedings of CRN's annual Scientific Symposium, which brought together experts to shed light on the critical issues surrounding global nutrition challenges and policy efforts.
pharmaphorum
NOVEMBER 30, 2023
PCR in pharma packaging: A sustainable solution for tomorrow? Mike.
Fierce Healthcare
NOVEMBER 30, 2023
Highmark Health brought in $20.3 billion in revenue and $431 million in net income for the first three quarters of 2023, the company said this week. | Highmark Health brought in $20.3 billion in revenue and $431 million in net income for the first three quarters of 2023, the company said this week.
Expert insights. Personalized for you.
503 
Let's personalize your content